16583545

Source:http://linkedlifedata.com/resource/pubmed/id/16583545

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0010186, umls-concept:C0021267, umls-concept:C0220812, umls-concept:C0872152
pubmed:issue	9
pubmed:dateCreated	2006-4-4
pubmed:language	swe
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0027707
pubmed:citationSubset	IM
pubmed:status	MEDLINE
pubmed:issn	0023-7205
pubmed:author	pubmed-author:JeppssonAndersA
pubmed:issnType	Print
pubmed:volume	103
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	663-4; discussion 664
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:16583545-Clinical Trials as Topic, pubmed-meshheading:16583545-Drug Costs, pubmed-meshheading:16583545-Drug Industry, pubmed-meshheading:16583545-Humans, pubmed-meshheading:16583545-Research, pubmed-meshheading:16583545-Research Support as Topic, pubmed-meshheading:16583545-Technology, Pharmaceutical
pubmed:articleTitle	[Drug development costs are overstated by the industry].
pubmed:affiliation	anders@hspstz.org
pubmed:publicationType	Journal Article